Kura Oncology (KURA) News Today $7.14 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$7.14 0.00 (0.00%) As of 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to "Buy"StockNews.com raised Kura Oncology from a "hold" rating to a "buy" rating in a research report on Wednesday.March 27 at 11:05 PM | marketbeat.comKura Oncology announces preclinical data for KO-2806 to be presented at AACRMarch 27 at 6:17 PM | markets.businessinsider.comKura Flat on DevelopmentsMarch 26 at 12:44 PM | baystreet.caKura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual MeetingMarch 26 at 7:30 AM | globenewswire.comKura Oncology (NASDAQ:KURA) Stock Price Down 2.7% - Should You Sell?Kura Oncology (NASDAQ:KURA) Stock Price Down 2.7% - Time to Sell?March 25 at 12:25 PM | marketbeat.comCantor Fitzgerald Expects Higher Earnings for Kura OncologyKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share (EPS) estimates for Kura Oncology in a research note issued on Wednesday, March 19th. Cantor Fitzgerald analyst L. Watsek now expects that the company will earMarch 22, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Stock Price Up 4.1% - Here's WhyKura Oncology (NASDAQ:KURA) Trading 4.1% Higher - Here's WhyMarch 21, 2025 | marketbeat.comPlatinum Investment Management Ltd. Boosts Position in Kura Oncology, Inc. (NASDAQ:KURA)Platinum Investment Management Ltd. increased its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 82.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,533 shares of the company's stoMarch 20, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Stock Rating Lowered by StockNews.comMarch 20, 2025 | americanbankingnews.comKura Oncology (NASDAQ:KURA) Rating Lowered to "Hold" at StockNews.comStockNews.com downgraded shares of Kura Oncology from a "buy" rating to a "hold" rating in a report on Tuesday.March 19, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives $25.50 Consensus Price Target from AnalystsMarch 18, 2025 | americanbankingnews.com147,943 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Acquired by Wealthfront Advisers LLCWealthfront Advisers LLC bought a new position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 147,943 shares of the company's stock, valued at approximately $1,289,000. Wealthfront AdviseMarch 16, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, seven have assigned a buy ratinMarch 15, 2025 | marketbeat.comBiotech startup looks to turn founders' experience, $20 million against epilepsyMarch 13, 2025 | bizjournals.comKura Oncology (NASDAQ:KURA) Stock Price Down 5.8% - What's Next?Kura Oncology (NASDAQ:KURA) Stock Price Down 5.8% - Time to Sell?March 12, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Hits New 52-Week Low - Should You Sell?Kura Oncology (NASDAQ:KURA) Hits New 52-Week Low - Here's WhyMarch 12, 2025 | marketbeat.comCandriam S.C.A. Cuts Position in Kura Oncology, Inc. (NASDAQ:KURA)Candriam S.C.A. lessened its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 53.4% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 422,652 shares of the company's stock after selling 483,830 shares durinMarch 9, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Price Target Lowered to $14.00 at UBS GroupUBS Group cut their price objective on Kura Oncology from $27.00 to $14.00 and set a "buy" rating for the company in a research report on Thursday.March 7, 2025 | marketbeat.comAnalysts Offer Predictions for Kura Oncology FY2025 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of Kura Oncology in a report released on Tuesday, March 4th. Cantor Fitzgerald analyst L. Watsek anticipates that the company will post earnMarch 7, 2025 | marketbeat.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 7, 2025 | globenewswire.comKura Oncology (NASDAQ:KURA) Rating Increased to Buy at StockNews.comStockNews.com upgraded shares of Kura Oncology from a "hold" rating to a "buy" rating in a research note on Friday.March 7, 2025 | marketbeat.comKura Oncology price target lowered to $14 from $27 at UBSMarch 6, 2025 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) Upgraded by Cantor Fitzgerald to "Strong-Buy" RatingCantor Fitzgerald raised shares of Kura Oncology to a "strong-buy" rating in a report on Tuesday.March 6, 2025 | marketbeat.comKura Oncology: The Market Sees A Tough Road Ahead, And I Think There's An OpportunityMarch 5, 2025 | seekingalpha.comLeerink Partnrs Forecasts Kura Oncology FY2026 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at Leerink Partnrs issued their FY2026 EPS estimates for shares of Kura Oncology in a research report issued to clients and investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang anticipates that the company wMarch 3, 2025 | marketbeat.comFY2025 EPS Estimate for Kura Oncology Reduced by AnalystKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Brookline Capital Management lowered their FY2025 earnings per share estimates for shares of Kura Oncology in a research note issued to investors on Wednesday, February 26th. Brookline Capital Management analyst L. CaMarch 3, 2025 | marketbeat.comHC Wainwright Predicts Kura Oncology Q2 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at HC Wainwright issued their Q2 2025 earnings estimates for Kura Oncology in a research note issued to investors on Thursday, February 27th. HC Wainwright analyst J. Pantginis expects that the company will post earnings of ($March 3, 2025 | marketbeat.comWedbush Estimates Kura Oncology's Q1 Earnings (NASDAQ:KURA)Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Wedbush lowered their Q1 2025 earnings per share (EPS) estimates for Kura Oncology in a research note issued to investors on Thursday, February 27th. Wedbush analyst R. Driscoll now anticipates that the company will post earningsMarch 3, 2025 | marketbeat.comResearch Analysts Set Expectations for Kura Oncology Q1 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Research analysts at Brookline Capital Management issued their Q1 2025 earnings per share (EPS) estimates for Kura Oncology in a report issued on Wednesday, February 26th. Brookline Capital Management analyst L. Cann anticipates that the company wMarch 1, 2025 | marketbeat.comHC Wainwright Comments on Kura Oncology Q1 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of Kura Oncology in a research report issued to clients and investors on Thursday, February 27th. HC Wainwright analyst J. Pantginis forecasts that the compaMarch 1, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Upgraded at StockNews.comStockNews.com raised shares of Kura Oncology from a "sell" rating to a "hold" rating in a research report on Thursday.February 28, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Earns Outperform Rating from WedbushWedbush restated an "outperform" rating and issued a $36.00 price objective on shares of Kura Oncology in a research note on Thursday.February 28, 2025 | marketbeat.comArgenx Se (ARGX) Gets a Buy from ScotiabankFebruary 28, 2025 | markets.businessinsider.comKura Oncology (NASDAQ:KURA) shareholders have endured a 64% loss from investing in the stock a year agoFebruary 28, 2025 | finance.yahoo.comKura Oncology (NASDAQ:KURA) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $40.00 price objective on shares of Kura Oncology in a report on Thursday.February 28, 2025 | marketbeat.comQ4 2024 Kura Oncology Inc Earnings CallFebruary 28, 2025 | finance.yahoo.comKura Oncology (NASDAQ:KURA) Announces Earnings ResultsKura Oncology (NASDAQ:KURA - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.65) by $0.43.February 27, 2025 | marketbeat.comKura Oncology, Inc. (KURA) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | seekingalpha.comKura Oncology, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 27, 2025 | seekingalpha.comKura Oncology reports Q4 EPS (22c), consensus (64c)February 26, 2025 | markets.businessinsider.comKura Oncology Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 26, 2025 | globenewswire.comKura Oncology to Participate in Three Upcoming Investor ConferencesFebruary 25, 2025 | globenewswire.comKura Oncology to Report Fourth Quarter and Full Year 2024 Financial ResultsFebruary 19, 2025 | globenewswire.comKura Oncology (KURA) to Release Earnings on TuesdayKura Oncology (NASDAQ:KURA) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of "Moderate Buy" from BrokeragesKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has received an average rating of "Moderate Buy" from the twelve ratings firms that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation andFebruary 18, 2025 | marketbeat.comKura Oncology's SWOT analysis: stock poised for pivotal year aheadFebruary 17, 2025 | msn.comScotiabank Sticks to Its Buy Rating for Inmune Bio (INMB)February 11, 2025 | markets.businessinsider.comBarclays PLC Buys 84,563 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Barclays PLC lifted its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 104.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 165,484 shares of the company's stock after purchasing an additional 84,563 shares during the quarterFebruary 11, 2025 | marketbeat.comAnalysts Set Expectations for Kura Oncology FY2029 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings estimates for shares of Kura Oncology in a research report issued to clients and investors on Thursday, February 6th. Wedbush analyst R. Driscoll anticipates that the company will earn $2.60 pFebruary 10, 2025 | marketbeat.comLeerink Partnrs Predicts Kura Oncology Q1 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Kura Oncology in a report issued on Wednesday, February 5th. Leerink Partnrs analyst J. Chang forecasts that the company will post earnings per share ofFebruary 10, 2025 | marketbeat.com Remove Ads Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.660.78▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼96▲KURA Articles Average Week Remove Ads Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IBRX News BEAM News VCEL News MIRM News EWTX News CNTA News KYMR News CGON News DNLI News BLTE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
